CLS Holdings USA, Inc. Debenture Agreements

20 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Unsecured Debenture
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Third Amended and Restated Debenture dated December 29, 2023, by and between the Company and Navy Capital Green Co-Invest Fund, LLC
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Third Amended and Restated Debenture dated December 29, 2023, by and between the Company and Navy Capital Green Fund, LP
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Form of Unsecured Debenture
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Navy Capital Green Fund LP in the principal amount of $500,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
AMENDED AND RESTATED UNSECURED DEBENTURE
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Tribeca Investment Partners in the principal amount of $500,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Tribeca Investment Partners in the principal amount of $500,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Ian Whitmore in the principal amount of $250,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Graham Saunders in the principal amount of $250,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Second Amended and Restated Convertible Debenture, dated September 15, 2022, issued to Navy Capital Green Co-Invest Fund, LLC
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2022
Second Amended and Restated Convertible Debenture, dated September 15, 2022, issued to Navy Capital Green Fund, LP
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2022
Form of Warrant issued in connection with the November 2021 Debenture Offering
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Form of Debenture issued in connection with the November 2021 Debenture Offering
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2022
Amended and Restated Convertible Debenture, dated April 19, 2021, issued to Darling Capital, LLC in the principal amount of $599,101
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2021
Amended and Restated Convertible Debenture, dated April 15, 2021, issued to Navy Capital Green Co-Invest Fund, LLC in the principal amount of $4,504,457
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2021
Amended and Restated Convertible Debenture, dated April 15, 2021, issued to Navy Capital Green Fund, LP in the principal amount of $1,126,114
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2021
Form of First Amendment to Convertible Debenture
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2019
Convertible Debenture dated July 20, 2018 in the original principal amount of $500,000 made by CLS Holdings USA, Inc. in favor of YA II PN, Ltd
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Convertible Debenture dated May 14, 2018 in the original principal amount of $750,000 made by CLS Holdings USA, Inc. in favor of YA II PN, Ltd
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018